
















































While the potential of digital health in Oncology remains untapped, advancements indicate promising avenues for integrating digital tools in cancer care.
Evidence suggests that electronic patient-reported outcomes (ePROs), for instance, contribute to improved symptom identification and symptom management. Additionally, the use of wearables in monitoring health-related data has demonstrated a positive impact on physical activity and quality of life.
Pharmaceutical companies find themselves re-evaluating the ‘traditional’ patient journey, continuously reassessing how technology can and should be deployed to gather deeper insights, enhance treatment experiences, and improve outcomes.
Join this roundtable discussion hosted by Bayer, inviting experts, healthcare providers, and digital health innovators to engage in a conversation about leveraging digital tools to enhance patient experiences, refine disease management strategies, and enable data-driven decision-making in cancer care.
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.